Search Results 2701-2710 of 14577 for Lupus

  1. Ixekizumab in the Treatment of Bullous Pemphigoid - Mayo Clinic

    Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...

  2. A Study To Evaluate Durvalumab Plus Topotecan Or Lurbinectedin In Patients With Small Cell Lung Cancer - Mayo Clinic

    The purpose of this study is to evaluate whether the combination of durvalumab plus lurbinectedin can increase 6 month progression-free survival, in patients ...

  3. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) - Mayo Clinic

    African Americans, Afro-Caribbeans, Hispanic Blacks, and Africans are more likely to have the APOL1 gene variants that cause kidney disease. APOLLO will test ...

  4. A Study To Evaluate The Effect Of Vitamin D On PFS In Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

    Despite strong evidence suggesting that vitamin D deficiency is associated with undesirable outcomes in patients with numerous cancers, there has never been a ...

  5. A Phase 2a Study Of TPN-101 In Patients With Progressive Supranuclear Palsy (PSP) - Mayo Clinic

    The primary objective of this study is to asssess the safety and tolerability of TPN-101 in patients with progressive supranuclear palsy (PSP). Participation ...

  6. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  7. A Study To Establish A Parkinson’s Disease (PD) Cohort Using The Parkinson’s Progression Markers Initiative (PPMI) - Mayo Clinic

    The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic ...

  8. A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety and Effectiveness of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate-to-Severe Hidradenitis Suppurativa - Mayo Clinic

    A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety ...

  9. Study of mouse gut microbiome may provide clues to how cancer develops in humans - Mayo Clinic News Network

    ROCHESTER, Minn. ― A study of the mouse gut microbiome led by researchers from Mayo Clinic may shed light on how cancerous tumors develop and progress in ...

  10. Publications - Anuradha Luke, M.D. - Mayo Clinic

    McCoy RG, Juntunen MB, Ridgeway JL, Hentz JG, Glasgow AE, Liedl C, Murley BM, Warrington CE, Sundt WJ, Krpata TS, Haugo OA, Lampman MA, Fink AL, ...